Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Jones

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
BMJ Open Diabetes Research & Care|April 22, 2022
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter studyAnxious J Niwaha, Lauren R Rodgers, Alice L J Carr, et al.
BMJ Open Diabetes Research & Care|August 29, 2024
Ethnic differences in the manifestation of early-onset type 2 diabetesDavis Kibirige, Jean-Claude Katte, Anita V Hill, et al.
Diabetologia|April 11, 2019
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetesNicholas J Thomas, Anita L Lynam, Anita V Hill, et al.
BMJ Open Diabetes Research & Care|September 18, 2021
HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter studyAnxious J Niwaha, Lauren R Rodgers, Rosamund Greiner, et al.
Diabetes|July 8, 2024
Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset DiabetesSian L Grace, Kathleen M Gillespie, Claire L Williams, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017John M Dennis, William E Henley, Andrew P McGovern, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 16, 2016
Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosisSuzy V Hope, Sophie Wienand-Barnett, Maggie Shepherd, et al.
The Lancet Regional Health. Europe|December 16, 2025
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort studyLaura M Güdemann, Katherine G Young, Pedro Cardoso, et al.
Diabetologia|November 9, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protectionThijs T Jansz, Katherine G Young, Rhian Hopkins, et al.
Diabetes Care|June 18, 2026
To Cluster or Not to Cluster? A Comparison of Approaches to Targeting Type 2 Diabetes Glucose-Lowering Therapy in the TriMaster Crossover TrialLaura M Güdemann, Catherine Angwin, Rury R Holman, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
BMJ Open Diabetes Research & Care|April 22, 2022
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter studyAnxious J Niwaha, Lauren R Rodgers, Alice L J Carr, et al.
BMJ Open Diabetes Research & Care|August 29, 2024
Ethnic differences in the manifestation of early-onset type 2 diabetesDavis Kibirige, Jean-Claude Katte, Anita V Hill, et al.
Diabetologia|April 11, 2019
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetesNicholas J Thomas, Anita L Lynam, Anita V Hill, et al.
BMJ Open Diabetes Research & Care|September 18, 2021
HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter studyAnxious J Niwaha, Lauren R Rodgers, Rosamund Greiner, et al.
Diabetes|July 8, 2024
Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset DiabetesSian L Grace, Kathleen M Gillespie, Claire L Williams, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017John M Dennis, William E Henley, Andrew P McGovern, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 16, 2016
Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosisSuzy V Hope, Sophie Wienand-Barnett, Maggie Shepherd, et al.
The Lancet Regional Health. Europe|December 16, 2025
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort studyLaura M Güdemann, Katherine G Young, Pedro Cardoso, et al.
Diabetologia|November 9, 2025
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protectionThijs T Jansz, Katherine G Young, Rhian Hopkins, et al.
Diabetes Care|June 18, 2026
To Cluster or Not to Cluster? A Comparison of Approaches to Targeting Type 2 Diabetes Glucose-Lowering Therapy in the TriMaster Crossover TrialLaura M Güdemann, Catherine Angwin, Rury R Holman, et al.
Pageof 10